QC Kinetix is a leading regenerative medicine provider, offering cutting-edge, non-surgical solutions for joint pain and musculoskeletal conditions. Since its founding in 2017, the company has experienced rapid growth, expanding to over 100 cities nationwide and helping thousands of patients find relief through advanced, non-invasive treatments.
QC Kinetix leverages regenerative medicine to activate the body’s natural healing processes, enhancing function and relieving musculoskeletal discomfort without the need for surgery.
In May 2024, QC Kinetix earned a spot among Entrepreneur’s top 10 New and Emerging Franchises. The publication highlighted the company’s impressive rise to No. 9, citing its strong unit expansion, financial stability, and growing brand presence as key factors in its ranking.
With an astounding 2,111% increase in unit growth over the past three years, the company has solidified its position among the industry’s leading brands.
“We’re honored to rank among some of the fastest-growing franchise brands,” said the CEO of QC Kinetix. “The recognition is a true testament to our entire team’s hard work and dedication. I’m excited to watch our brand continue to grow and push the boundaries of what’s possible in the regenerative medicine industry.”
QC Kinetix Gains Support from Leading Experts in the Industry
QC Kinetix is dedicated to offering patients a superior, non-surgical solution for pain relief. Their mission is rooted in a commitment to helping individuals regain their quality of life without relying on medications, surgery, or steroids. Through innovative biologic treatment protocols, they have successfully improved the lives of thousands, demonstrating their unwavering focus on patient care.
QC Kinetix has appointed globally recognized orthopedic surgeon Dr. Mitchell Sheinkop as its national medical director.
Joining QC Kinetix marks a new chapter for him, bringing over 37 years of expertise in joint replacement surgery. His decision to collaborate with the company underscores his confidence in the transformative potential of regenerative medicine and his dedication to enhancing patient care.
As the new medical director at QC Kinetix, Dr. Sheinkop will lead the medical management team, refining treatment protocols and driving research and development to ensure the franchise remains at the forefront of medical innovation. His vision includes integrating physical therapy and weight management into existing treatment plans to enhance patient outcomes, improve overall satisfaction, and strengthen the brand’s impact.
As QC Kinetix embarks on an exciting new chapter under Dr. Sheinkop’s leadership, his vast expertise—combining exceptional clinical accomplishments with a deep commitment to education and professional advancement—makes him the ideal leader to drive the company toward new heights of innovation and success.
QC Kinetix is also supported by renowned athletes, including Pro Football Hall of Famer Emmitt Smith, who represents the brand as its national spokesperson.
“I’ve got to keep taking care of these joints,” Smith said, “no losing for this guy. When I take QC Kinetix natural supplements, it’s like – bam – Emmitt 2.0. Sometimes, you need a competitive edge.”
An Overview of QC Kinetix
A Doctor, Physician Assistant, Nurse Practitioner, and Business Expert Come Together
Driven by a vision and ambition, they set out to name their new company. Wanting to honor their roots in Charlotte, North Carolina—often called the “Queen City” (QC)—they found inspiration for the first part of their brand identity.
The name “Kinetix” is derived from kinetic energy, symbolizing movement and activity. QC Kinetix is dedicated to restoring mobility by harnessing the body’s own regenerative abilities to promote healing and recovery.
The visionaries behind QC Kinetix saw an opportunity to revolutionize the treatment of musculoskeletal pain. Determined to move beyond conventional methods, they developed a state-of-the-art concierge medical model focused on regenerative medicine, offering a safer and more effective path to restoring patients’ quality of life. Their dedication to innovation distinguishes QC Kinetix and fuels their mission to advance the field of regenerative healthcare.
For many individuals, pain limits their ability to enjoy daily activities such as golfing, climbing stairs, or spending time with their grandchildren. QC Kinetix provides an advanced treatment solution that eliminates the need for risky surgeries, toxic steroid injections, or potentially harmful medications.
“No longer did we want insurance to tell us what they were willing to pay to treat a patient,” a company spokesperson stated. “We wanted the research to tell us the most effective method, whether it was covered by insurance or not, and bring it to the United States in a very transparent and patient-focused manner. QC Kinetix is an opportunity to become the first option when dealing with pain, not the alternative to those ways. That is our mission over time.”
QC Kinetix Pioneers a Patient-Focused Approach to Care
QC Kinetix is at the forefront of regenerative medicine, offering advanced treatments that help individuals stay active by effectively managing musculoskeletal and joint pain.
They have helped thousands of patients find relief through innovative biologic treatment protocols.
QC Kinetix harnesses the body’s natural healing abilities with cutting-edge biological treatments, providing a non-invasive alternative to surgery and dependency on pain medications.
The clinics focus on enhancing the body’s natural healing and repair processes, promoting improved function and a better quality of life from within.
Patients often seek treatment for knee, shoulder, or hip pain. QC Kinetix utilizes the body’s natural regenerative abilities to promote healing and restore function. Since its inception, the company has achieved numerous significant milestones.
In 2023, QC Kinetix surpassed $100 million in system-wide sales, and by April 2024, the company had treated its 40,000th patient since launching its national expansion in 2021.
“It is our goal to change medicine,” stated the CEO of QC Kinetix. “We want to be the first thing people think about when they or a loved one are dealing with pain. We measure that success by seeing feedback from our patients that we could change their lives. We aim to care for our patients and employees first, knowing that growth and profit will follow.”
QC Kinetix Poised for a Groundbreaking Medical Advancement
Having established a strong presence in the United States, QC Kinetix is now focused on global expansion. The company plans to enter the United Kingdom, Australia, and New Zealand in the coming years, reinforcing its position as a leader in regenerative medicine worldwide.
QC Kinetix is striving to reach 250 operational locations across the United States by the close of 2024.
Achieving such rapid expansion in just four years of franchising is remarkable. However, the CEO of QC Kinetix expressed that the only surprise is that growth hasn’t been even faster, given the increasing demand for non-surgical pain relief options. The company’s swift rise underscores both the strong consumer interest in alternatives to pain medications and surgery, as well as the growing enthusiasm among franchise investors in the medical industry.
“I love this brand and our future,” said the CEO of QC Kinetix. “It’s about impacting people’s lives and being a game-changer in the medical field.”